BTCY
BIOTRICITY INC.
Key Financials
Gross Profit
$10.6M
↑ 26.4%
Operating Income
$-2448966
↑ 72.3%
Revenue
$13.8M
↑ 14.3%
Net Income
$-8421179
↑ 40.3%
Shareholders' Equity
$-32014390.00
↓ 1.7%
EPS (Diluted)
$-0.56
↑ 66.6%
Total Liabilities
$35.7M
↓ 0.7%
Total Assets
$5.6M
↓ 5.1%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| NT 10-K | 6/29/2026 | View on SEC |
| DEF 14C | 6/16/2026 | View on SEC |
| PRE 14C | 5/29/2026 | View on SEC |
| SCHEDULE 13G/A | 5/12/2026 | View on SEC |
| 8-K | 5/1/2026 | View on SEC |
| 8-K | 2/18/2026 | View on SEC |
| 10-Q | 2/11/2026 | View on SEC |
| SCHEDULE 13G/A | 2/4/2026 | View on SEC |
| S-1 | 12/19/2025 | View on SEC |
| 8-K | 11/18/2025 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | BTCY |
| Company Name | BIOTRICITY INC. |
| CIK | 1630113 |
| Sector | Surgical & Medical Instruments & Apparatus |
| Industry | Non-accelerated filer Smaller reporting company |
| Exchange | OTC |
| SIC Code | 3841 |
| SIC Description | Surgical & Medical Instruments & Apparatus |
| Entity Type | operating |
| Fiscal Year End | 0331 |
| State of Incorporation | NV |
| Phone | (800) 590-4155 |